Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors

Author:

Chen Chang-Long12,Pan Qiu-Zhong12,Weng De-Sheng12,Xie Chuan-Miao3,Zhao Jing-Jing12,Chen Min-Shan24,Peng Rui-Qing1,Li Dan-Dan1,Wang Ying5,Tang Yan12,Wang Qi-Jing1,Zhang Zhi-Ling6,Zhang Xiao-Fei12,Jiang Li-Juan6,Zhou Zi-Qi12,Zhu Qian12,He Jia1,Liu Yuan12,Zhou Fang-Jian26,Xia Jian-Chuan12

Affiliation:

1. Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

2. Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China

3. Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China

4. Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

5. Department of Immunization Program, Haizhu District Center for Disease Control and Prevention, Guangzhou, China

6. Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China

Funder

National Natural Science Foundation for Young Scholar of China

Guangdong Province Science and Technology Plan Project

National Natural Science Foundation of China (NSFC)

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3